| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 03/07/2002 | US20020028807 5,11-Dihydro-11-ethyl-5-methyl-8-(2-((1-oxido-4-quinolinyl) oxy)ethyl)-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one for example; inhibitor of HIV replication; treating or preventing HIV infection |
| 03/07/2002 | US20020028766 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 03/07/2002 | US20020028245 Compact member, method of manufacturing and use thereof |
| 03/07/2002 | US20020028183 Medicaments |
| 03/07/2002 | US20020028178 Treating CD40+ malignancies comprising administering a therapeutically effective amount of an antibody or antibody fragment which binds to CD40L thereby inhibiting CD40/CD40L interaction or CD40 signaling. |
| 03/07/2002 | CA2697205A1 Peptidomimetic protease inhibitors |
| 03/07/2002 | CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | CA2420363A1 Pyrazole derivatives and their use as protein kinase inhibitors |
| 03/06/2002 | EP1096944B1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 03/06/2002 | EP0756595B1 Substituted 1,3-oxathiolanes with antiviral properties |
| 03/06/2002 | CN1338937A Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
| 03/06/2002 | CN1338936A Drug-combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of P450 |
| 03/06/2002 | CN1338580A Safety device of fluid speed varying apparatus |
| 03/06/2002 | CN1338250A Composition containing cationic amphiphic polymer, oxidized alkenylated or glycerinated fatty alcohol and hydroxylated solvent for oxidizing dyeing keration fibers |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6353015 Indole derivatives for nervous system disorders |
| 03/05/2002 | US6352986 Treatments for nervous disorders |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | US20020025299 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 02/28/2002 | DE10040700A1 Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung Salts of biologically active peptides, their preparation and use |
| 02/27/2002 | EP1181940A2 In vivo diagnostics by near infrared radiation |
| 02/27/2002 | EP1181298A1 Novel 8a- and 9a-15-membered lactams |
| 02/27/2002 | EP1181294A1 Novel derivatives and analogues of galanthamin |
| 02/27/2002 | EP1181289A1 Polymorphs of crystalline (2-benzhydryl-1-azabicyclo[2.2.2]oct-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as nk-1 receptor antagonists |
| 02/27/2002 | EP1181057A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 02/27/2002 | EP1181054A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders |
| 02/27/2002 | EP1181030A2 Tanacetum parthenium extract |
| 02/27/2002 | EP1181027A2 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 02/27/2002 | EP1181021A1 Novel, specific inhibitors of acute and chronic inflammation |
| 02/27/2002 | EP1021162B1 Cosmetic compositions containing azelaic acid |
| 02/27/2002 | CN1337964A Novel aralkyl amines of spirofuropyridines useful in therapy |
| 02/27/2002 | CN1337956A New Morpholinobenzamide salts |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337947A Acetylenic sulfonamide thiol TACE inhibitors |
| 02/27/2002 | CN1337882A Pharmaceutical composition for the treatment o f rheumatic syndromes containing sulfur, mustard seeds and a copper salt |
| 02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
| 02/27/2002 | CN1079664C 口腔用组合物 Oral composition |
| 02/26/2002 | US6350907 Matrix metalloprotease inhibitors |
| 02/26/2002 | US6350478 Artemisia judaica fractionation method |
| 02/26/2002 | US6350449 Immune composition comprising antibodies raised in mammal immunized with conjugate molecule comprising group b meningococcal polysaccharide having n-acetyl groups replaced with unsaturated acyl groups, covalently bound to protein |
| 02/26/2002 | US6350437 Tooth pastes |
| 02/26/2002 | CA2284470C New crystalline form of omeprazole |
| 02/26/2002 | CA2195094C Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases |
| 02/26/2002 | CA2072484C Use of nadh or nadph against cancer and aids |
| 02/26/2002 | CA2046801C Substituted pyrroles |
| 02/21/2002 | WO2002014347A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002013766A2 Valproic acid derivatives for the treatment of pain |
| 02/21/2002 | WO2001080619A3 Pharmaceutical composition containing citalopram |
| 02/21/2002 | US20020022612 Nitrogen containing heterocyclic compounds useful as anticoagulants |
| 02/21/2002 | CA2418455A1 Valproic acid derivatives for the treatment of pain |
| 02/20/2002 | EP1180110A1 13-methyl-erythromycin derivatives |
| 02/20/2002 | EP1180102A1 Mutual prodrugs of amlodipine and atorvastatin |
| 02/20/2002 | EP1180006A2 Compositions and methods for their preparation from lepidium |
| 02/20/2002 | EP1142578A4 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 02/20/2002 | EP1017362B1 Fluoride dentifrices of enhanced efficacy |
| 02/20/2002 | CN1079230C Permannet wave composition and method |
| 02/19/2002 | US6348597 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 02/19/2002 | US6348474 Compounds as antidiabetic agents |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012215A1 Process for the preparation of baccatin iii derivatives |
| 02/14/2002 | WO2002011687A2 Epilatory compositions |
| 02/14/2002 | WO2001076531A3 Bile acid containing prodrugs with enhanced bioavailability |
| 02/14/2002 | US20020019991 Compositions containing an alpha 1,2-fucose linkage and uses thereof |
| 02/14/2002 | US20020019530 Antitumor agent |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020018810 Controlled release oxycodone compositions |
| 02/14/2002 | US20020018788 Trimethylglycine compound |
| 02/13/2002 | EP1179533A2 Salt of naphthyridine carboxylic acid derivative |
| 02/13/2002 | EP1179336A1 Oxidative dyeing composition for keratinic fibres comprising an cationic amphiphylic polymer, an oxyalkylated or glycerolated fatty alcohol, and a hydroxyl solvent |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178810A2 Use of bisphosphonic acids for treating angiogenesis |
| 02/13/2002 | EP1178808A1 Pharmaceutical composition |
| 02/13/2002 | EP1178775A1 Antiperspirant stick |
| 02/13/2002 | CN1335846A Pyrano, piperidino and thiopyrano compounds and methods of use |
| 02/13/2002 | CN1335843A Thiourea inhibitors of herpes viruses |
| 02/13/2002 | CN1335839A Bis-sulfonamides |
| 02/13/2002 | CN1335774A Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition |
| 02/13/2002 | CN1335766A A process for the preparation of suspensions of drug particles for inhalation delivery |
| 02/13/2002 | CN1335763A Skin care compositions containing cis-9, trans-11 linoleic acid |
| 02/13/2002 | CN1079027C Medical composition for treating diabetes |
| 02/12/2002 | US6346613 An antisense oligonucleotide that hybridizes with a occludin mrna and disrupts tight junctions, to increase cell layer permeability to solutes and drugs |
| 02/12/2002 | US6346275 Drugs for immunology residues of corallinaceae, seaweed derivatives |
| 02/12/2002 | CA2303685C Fluorocarbon aerosol medicaments |
| 02/12/2002 | CA2131547C Composition for oral preparations |
| 02/12/2002 | CA2057504C Process for preparing new n-acyl-2,3-benzodiazepine derivatives, their acid addition salts and pharmaceutical compositions containing the same |
| 02/07/2002 | WO2002010163A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | WO2002010162A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases |
| 02/07/2002 | WO2002010125A1 Crystalline and pure modafinil, and process of preparing the same |
| 02/07/2002 | WO2001047477A3 Agent for dyeing keratin containing fibers |
| 02/07/2002 | US20020016463 Partial fatty acid oxidation inhibitors; protect skeletal muscles against damage resulting from trauma or systemic diseases, treat shock conditions, preserve donor tissue and organs used in transplants |
| 02/07/2002 | US20020016334 Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD) |
| 02/07/2002 | US20020015737 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/07/2002 | CA2417260A1 Process for preparing azacycloalkanoylaminothiazoles |
| 02/07/2002 | CA2417254A1 N-¢5-¢¢¢5-alkyl-2-oxazolyl!methyl!thio!-2-thiazolyl! carboxamide inhibitors of cyclin dependent kinases |
| 02/06/2002 | EP1178041A1 Process for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives |
| 02/06/2002 | EP1177798A2 A pharmaceutical composition for the treatment of attention deficit hyperactivity disorder(ADHD) comprising a nicotine receptor partial agonist and anti-ADHD agent |
| 02/06/2002 | EP1177195A1 1-AMINO TRIAZOLO 4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/06/2002 | EP1176967A1 Management of pain after joint surgery |